Multiple myeloma (MM) treatment has changed tremendously, with significant improvement in patient out-comes. One group with a suboptimal benefit is patients with high-risk cytogenetics, as tested by ...
CHATSWORTH, Calif., Nov. 29, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and a provider of high value personalized ...
Karyotype analysis includes complete chromosome analysis of at least twenty metaphases with at least two cut karyotypes. The presence or absence of an acquired clonal chromosomal abnormality may aid ...
Integration of AI with image-based genomics, consolidation towards integrated platforms, and growing focus on companion diagnostics bolster growthDublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The ...
Chronic myeloid leukemia (CML) is a blood and bone marrow cancer. It results in the production of too many immature blood cells, called myeloblasts. Doctors can classify CML into 3 phases using lab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results